Anavex Life Sciences Corp (AVXL)

[falconer66a]

Eventually, It Will Be Anavex Prophylaxis

Presently, appropriately, the focus of Anavex therapies is on developed, in-place disease states; Rett syndrome, Parkinson’s Disease, and Alzheimer’s. Well and good. A wide body of evidence supports this initial disease targeting. As I just noted, new diseases and conditions will be added in coming months and years.

But all of those involve the correction of various cell malfunctions, where things chronically (over time) have gone wrong. Anavex 2-73 will be used to restore normal cell processes, thereby restoring normalized health.

Which, however, would be more difficult, fixing cells and organs that have been chronically diseased (for years); or, to prevent biochemical dysfunctions before they become pathologic?

I foresee the strong possibility of Anavex drugs of having a Prevent It First approach; where the drugs are taken early, without any prior disease indications — to prevent (prophylaxis), not to treat or cure various diseases.

The new Anavex patent claims a potential therapy for “cardiac dysfunction.” Ok, then, when do you want your loved one to begin such therapy? Months or years after heart function has become symptomatically compromised? Or, before any such symptoms first appear; thereby preventing the onset of heart disease?

What if chronic (long-term) administration of Anavex 2-73 proves to be utterly without side effects? (Wait! Isn’t that the experience of those Australians continuing to take Anavex 2-73 now for how many dozens of months?)

Why not, then, prophylactically prescribe Anavex 2-73 for patients in their early adult years who, for example, have a family history of mid-life heart problems?

Because Anavex 2-73 has such a diversity of efficacies against a wide range of central nervous system diseases and conditions, applications for a larger number of brain-based diseases will be considered, not just the dementias of Parkinson’s and Alzheimer’s.

The Anavex pipeline suggests some efficacies against certain cancers.

In short, Anavex molecules may be the closest thing to a fountain (well, pill) of youth. A big, real anti-aging drug. What might be the social and financial implications if Anavex might prevent, not just treat, about 10% of the diseases of modern medicine? Not out of the question, at all.